Hinduja I, Mehta R, Gopalkrishnan K, Puri C P, Shah J, Singh V, Kumar T C
Department of Obstetrics & Gynecology, King Edward Memorial Hospital, Bombay.
Indian J Med Res. 1991 Dec;94:405-12.
Four different ovarian stimulation protocols were evaluated in an in vitro fertilisation and embryo transfer programme in 208 women (228 treatment cycles). In the rigid protocol (RP), 100 mg of clomiphene citrate (CC) was given from day 3 to day 7 of the menstrual cycle and 300 IU of human menopausal gonadotropin (hMG) was given from day 5 of the menstrual cycle. In the individualised protocol (IP) the same drugs and doses were used as in RP, but the day of initiation of CC depended on the length of the individual's menstrual cycle and hMG was administered from the last day of CC. In the programmed protocol (PP), ovarian function was suppressed with oral contraceptive pills (ethinyl estradiol 30 micrograms and norethisterone 1 mg) started on day 5 of the menstrual cycle for 45 to 70 days. Considering the last day of pill intake as day 0, CC was given for 5 days from day 5 and hMG (300 IU) from day 7. In the alternate day protocol (ADP), 100 mg of CC was administered from day 2 to day 6 and hMG (300 IU) was given on alternate days from day 2 to day 8 or day 10 of the cycle. In all the women, hCG (5000 IU) was administered when the diameter of at least 2 follicles was greater than or equal to 16 mm and estradiol levels were 300 pg/ml/dominant follicle. Patients not showing such a response were not treated further. The cardinal events of IVF-ET such as number of good responders, incidence of oocytes harvested, fertilised and embryos transferred per cycle were compared and it was concluded that the pregnancy rates were highest in women treated by the PP.
在一项针对208名女性(228个治疗周期)的体外受精和胚胎移植项目中,评估了四种不同的卵巢刺激方案。在严格方案(RP)中,月经周期第3天至第7天给予100毫克枸橼酸氯米芬(CC),月经周期第5天给予300国际单位人绝经期促性腺激素(hMG)。在个体化方案(IP)中,使用与RP相同的药物和剂量,但CC开始使用的日期取决于个体月经周期的长度,hMG从CC的最后一天开始给药。在程序化方案(PP)中,月经周期第5天开始口服避孕药(炔雌醇30微克和炔诺酮1毫克)抑制卵巢功能,持续45至70天。将服药的最后一天视为第0天,从第5天开始给予CC 5天,从第7天开始给予hMG(300国际单位)。在隔日方案(ADP)中,从周期第2天至第6天给予100毫克CC,从周期第2天至第8天或第10天隔日给予hMG(300国际单位)。在所有女性中,当至少2个卵泡直径大于或等于16毫米且雌二醇水平为300皮克/毫升/优势卵泡时,给予人绒毛膜促性腺激素(hCG,5000国际单位)。未出现这种反应的患者不再进一步治疗。比较了体外受精-胚胎移植的主要事件,如每个周期的良好反应者数量、收获的卵母细胞数量、受精的卵母细胞数量和移植的胚胎数量,得出结论:接受PP治疗的女性妊娠率最高。